Copyright
©2014 Baishideng Publishing Group Inc.
World J Stem Cells. Jul 26, 2014; 6(3): 278-287
Published online Jul 26, 2014. doi: 10.4252/wjsc.v6.i3.278
Published online Jul 26, 2014. doi: 10.4252/wjsc.v6.i3.278
Figure 3 Attenuation of aortic aneurysm development and growth is associated with improvement of the imbalance between degradation and synthesis of extracellular matrices by bone marrow-derived mesenchymal stem cell therapy.
ECM: Extracellular matrices; BM-MSC: Bone marrow-derived mesenchymal stem cell; TIMP: Tissue inhibitor of metalloproteinase; MMP: Matrix metalloproteinase; IL: Interleukin; IGF: Insulin-like growth factor.
- Citation: Yamawaki-Ogata A, Hashizume R, Fu XM, Usui A, Narita Y. Mesenchymal stem cells for treatment of aortic aneurysms. World J Stem Cells 2014; 6(3): 278-287
- URL: https://www.wjgnet.com/1948-0210/full/v6/i3/278.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v6.i3.278